- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
Report GEFBIN, FOCGO, DAGOCTI, CAMOAS, EGUDIN – Nhan Hau International Clinic
On the morning of December 18, 2019, at Nhan Hau International General Clinic (522-524 Nguyen Chi Thanh, Ward 7, District 10), Medbolide Joint Stock Company had a report to introduce the product GEFBIN (Ebastine 20mg) , FOCGO (Lornoxicam 8mg), DAGOCTI (Dutasteride 0.5mg), CAMOAS (Flavoxate 200mg), EGUDIN (Solifenacin 10mg). The reporting session took place with the attendance of BS.CKI. Nguyen Hai Nam (Director) and all the doctors of the clinic.
After the report, the doctors had many interesting discussions about how to use drugs, the meaning of pharmacokinetic parameters and the overall treatment costs of drugs.
At the end of the report, the representative of Medbolide Company summarized the main points and sent thanks to the Doctors, hoping to have the opportunity to continue accompanying the Clinic and Patients.
Readers comments